Rajeev Saggar
Chief Tech/Sci/R&D Officer en LIQUIDIA CORPORATION .
Fortuna: 3 M $ al 31/03/2024
Perfil
Rajeev Saggar is currently the Chief Medical Officer at Liquidia Corp.
Prior to this, he was the Vice President of Clinical Development at Theravance Biopharma US, Inc. from 2021 to 2022.
He also served as the Medical Director for Pulmonary Hypertension & Fibrosis at The Banner-University Medical Center.
Dr. Saggar holds a doctorate degree from the University of California, Irvine.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LIQUIDIA CORPORATION
0.28% | 19/04/2024 | 211 672 ( 0.28% ) | 3 M $ | 31/03/2024 |
Cargos activos de Rajeev Saggar
| Empresas | Cargo | Inicio |
|---|---|---|
| LIQUIDIA CORPORATION | Chief Tech/Sci/R&D Officer | 18/07/2022 |
Antiguos cargos conocidos de Rajeev Saggar.
| Empresas | Cargo | Fin |
|---|---|---|
Theravance Biopharma US, Inc.
 Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01/07/2022 |
| The Banner-University Medical Center | Corporate Officer/Principal | - |
Formación de Rajeev Saggar.
| University of California, Irvine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| LIQUIDIA CORPORATION | Health Technology |
| Empresas privadas | 1 |
|---|---|
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- Rajeev Saggar
